Credit card
Bank transfer
Cash on delivery**
Cart (0)
Total
0,00 €
Grow - 17/05/2023 Contributor
Nouvelles en surbrillance
STCM Conference “Cannabinoids in Medicine – New Trends” hosted in Bern
The Swiss Task Force for Cannabinoids in Medicine (STCM) Conference 2016 is taking place tomorrow in Auditorium E. Rossi, Inselspital-University Hospital Bern (Switzerland). STCM was founded in 2009 by clinicians, pharmacists, lawyers and other professionals with a…
Advantages of the CBD-rich strains
At this stage, we are pretty sure that most of you have enough information to give a conference about THC, on its properties and its effects. But, what about CBD? Cannabidiol is the second cannabinoid…
Australia now accepting applications for medical cannabis production
Canadian medical cannabis producers are expected to be among those to apply to produce cannabis crops for medical and scientific purposes. Australia’s Office of Drug Control begins accepting applications from private business for cannabis cultivation…
Cannabis use for sciatica & chronic low back pain
Low back pain is a common condition affecting many individuals at some point in their lives. [1] The estimation is that between 5.0% and 10.0% of cases will develop chronic low back pain (CLBP), which is…
Cannabis and lung health: a two-sided issue
How does smoking – the most popular form of cannabis administration – affect lung function? How does smoking – the most popular form of cannabis administration – affect lung function? Coughing, a common symptom of…
Turkey legalises cannabis production for scientific purposes
Many countries around the world struggle to implement pro-cannabis regulations, such as Morocco, Germany and some USA states. Turkey has already taken a step forward. The Turkish Ministry of Food, Agriculture and Livestock has approved…
Germany: First patient given permission to grow cannabis for personal use
On 28 September the Federal Institute for Drugs and Medical Devices, an agency of the Federal Health Ministry, issued its first permit allowing a 57-year-old patient suffering from multiple sclerosis to grow cannabis for his…
Cannabidiol improves severe form of childhood epilepsy in controlled clinical trial
The manufacturer of the CBD extract Epidiolex, GW Pharmaceuticals, reported of positive results of the second placebo-controlled Phase 3 clinical trial of this preparation for the treatment of seizures associated with Lennox-Gastaut syndrome, a rare…
